Strengthening the biochemical and immunoassay testing business through the acquisition of JEOL’s medical equipment business

An individual M&A transaction to strengthen the medical testing portfolio by acquiring JEOL’s medical equipment business together with the new company resulting from an absorption-type company split, incorporating analytical instruments, reagents, global sales and customer care in the biochemical and immunoassay testing fields.